Home › Hypopharyngeal Cancer › New Jersey › Edison
Hypopharyngeal Cancer clinical trials in Edison, NJ
4 studies for Hypopharyngeal Cancer are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RecruitingPhase 2
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
Hypopharyngeal Cancer trials in other cities
- Atlanta, GA6 studies
- Chicago, IL6 studies
- Richmond, VA5 studies
- Kansas City, MO5 studies
- Peoria, IL5 studies
- Bloomington, IL5 studies
- Milwaukee, WI5 studies
- Cape Girardeau, MO5 studies
- Wausau, WI5 studies
- Stevens Point, WI5 studies
- Joliet, IL5 studies
- Cincinnati, OH4 studies
Other studies in Edison
- Breast Cancer68 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer20 studies
- Metastatic Cancer20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.